UroGen Pharma Ltd.·4

Jul 30, 4:08 PM ET

Barrett Elizabeth A. 4

4 · UroGen Pharma Ltd. · Filed Jul 30, 2025

Insider Transaction Report

Form 4
Period: 2025-07-28
Barrett Elizabeth A.
Chief Executive Officer
Transactions
  • Award

    Performance Stock Units

    2025-07-28+87,61587,615 total
    Ordinary Shares (87,615 underlying)
Footnotes (2)
  • [F1]Each performance stock unit represents a contingent right to receive one ordinary share of the Issuer.
  • [F2]Represents performance stock units ("PSUs") granted to the reporting person on January 31, 2024 that were earned upon the achievement of a corporate milestone event. These PSUs remain subject to continued service through December 31, 2025, at which time they will vest and settle in ordinary shares.

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4